BINEX Co. Ltd
BINEX Co., Ltd. operates as a pharmaceutical company in South Korea. It offers bisroot products; GI tract and antispasmodic, and antiulcer agents; NSAIDs; cardiovascular and urology products; hepatic protectors; ointments and creams; ophthalmic solutions; CNS agents; digestive products; constipation and blood circulation products; antibiotic and antifungal agents; cough and cold remedy products; … Read more
BINEX Co. Ltd (053030) - Total Liabilities
Latest total liabilities as of September 2025: ₩117.14 Billion KRW
Based on the latest financial reports, BINEX Co. Ltd (053030) has total liabilities worth ₩117.14 Billion KRW as of September 2025.
Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities.
BINEX Co. Ltd - Total Liabilities Trend (2004–2024)
This chart illustrates how BINEX Co. Ltd's total liabilities have evolved over time, based on quarterly financial data. Explore and compare other companies by total liabilities.
BINEX Co. Ltd Competitors by Total Liabilities
The table below lists competitors of BINEX Co. Ltd ranked by their total liabilities.
| Company | Country | Total Liabilities |
|---|---|---|
|
First of Long Island Corp
NASDAQ:FLIC
|
USA | $3.69 Billion |
|
SANDUR MANGANESE AND IRON ORES LTD
NSE:SANDUMA
|
India | ₹28.85 Billion |
|
Compagnie du Bois Sauvage SA
BR:COMB
|
Belgium | €186.49 Million |
|
Guangzhou Newlife New Material Co. Ltd. A
SHE:301323
|
China | CN¥145.26 Million |
|
Aspen Aerogels Inc
NYSE:ASPN
|
USA | $185.66 Million |
|
Hidrovias do Brasil S.A
SA:HBSA3
|
Brazil | R$4.33 Billion |
|
Jilin Jlu Communication Design Institute Co Ltd
SHE:300597
|
China | CN¥584.24 Million |
|
Beijing Seeyon Internet Software Cp
SHG:688369
|
China | CN¥518.59 Million |
Liability Composition Analysis (2004–2024)
This chart breaks down BINEX Co. Ltd's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted.
Liquidity & Leverage Metrics
Key Metrics Explained
| Metric | Value | Description |
|---|---|---|
| Current Ratio | 1.62 | Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities) |
| Quick Ratio | N/A | More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities) |
| Cash Ratio | N/A | Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities) |
| Debt to Equity | 0.63 | Measures financial leverage (Total Liabilities ÷ Shareholder Equity) |
| Debt to Assets | 0.38 | Portion of assets financed with debt (Total Liabilities ÷ Total Assets) |
Liability Trends Comparison
This chart compares key liability metrics across different time periods, showing how BINEX Co. Ltd's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.
Annual Total Liabilities for BINEX Co. Ltd (2004–2024)
The table below shows the annual total liabilities of BINEX Co. Ltd from 2004 to 2024.
| Year | Total Liabilities | Change |
|---|---|---|
| 2024-12-31 | ₩97.78 Billion | +29.19% |
| 2023-12-31 | ₩75.69 Billion | -29.14% |
| 2022-12-31 | ₩106.80 Billion | +16.00% |
| 2021-12-31 | ₩92.07 Billion | -4.96% |
| 2020-12-31 | ₩96.88 Billion | +129.10% |
| 2019-12-31 | ₩42.29 Billion | +3.17% |
| 2018-12-31 | ₩40.99 Billion | +5.04% |
| 2017-12-31 | ₩39.02 Billion | +6.76% |
| 2016-12-31 | ₩36.55 Billion | +14.32% |
| 2015-12-31 | ₩31.97 Billion | +28.80% |
| 2013-12-31 | ₩24.82 Billion | -52.18% |
| 2012-12-31 | ₩51.90 Billion | +72.44% |
| 2011-12-31 | ₩30.10 Billion | +105.73% |
| 2007-12-31 | ₩14.63 Billion | +1.63% |
| 2006-12-31 | ₩14.40 Billion | +6.15% |
| 2005-12-31 | ₩13.56 Billion | -26.46% |
| 2004-12-31 | ₩18.44 Billion | -- |